LONDON, July 10, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX) today closed its previously announced exercise of certain outstanding preferred investment options to purchase up to an aggregate of 548,000 ordinary shares of the Company, par...
Hence then, the article about virax biolabs group limited announces closing of exercise of preferred investment options for 3 3 million gross proceeds was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds )
Also on site :
- Dolly Parton donated $1 million to Vanderbilt University Medical Center in 2020 to help fund the critical early research behind Moderna’s COVID-19 vaccine
- In 1984, Alabama Released the Wrong Song as a Single; Radio DJs Flipped the Record Over and Made the B-Side Their 14th Straight No. 1
- Who Went Home on ‘Dancing With the Stars’ Tonight? Season 35 Week 8 Results and Eliminations (Spoilers)